[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335951-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335951-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","therapeutic-restoration-of-mir-126-3p-as-a-multi-targeted-strategy-to-modulate-the-liver-tumor-microenvironment","Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment","","Impaired NK cell–mediated antitumor responses drive liver tumor growth. ADAM9 increases shedding of MICA and enables NK cell immune evasion, while also promoting angiogenesis and tumor progression; miR-126-3p is a tumor-suppressive miRNA downregulated in liver tumors. The study assesses restoring miR-126-3p and modulating the miR-126-3p/ADAM9 axis to enhance NK cytolysis while targeting tumor cells and their microenvironment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/therapeutic-restoration-of-mir-126-3p-as-a-multi-targeted-strategy-to-modulate-the-liver-tumor-microenvironment/335951/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/therapeutic-restoration-of-mir-126-3p-as-a-multi-targeted-strategy-to-modulate-the-liver-tumor-microenvironment/335951.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does this study address in liver cancer?","Question",{"text":63,"@type":64},"The study addresses NK cell dysfunction that allows tumor cells to evade NK cell–mediated cytolysis and promote tumor growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is miR-126-3p restoration delivered?",{"text":68,"@type":64},"Precursor miRNAs are loaded into milk-derived nanovesicles to create therapeutic vesicles for restoring functional miR-126-3p in recipient cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What main outcomes were observed after treatment?",{"text":72,"@type":64},"Treatment increased miR-126-3p and reduced ADAM9, enhanced MICA-mediated NK cytolysis, impaired angiogenesis, modulated macrophage chemotaxis, and reduced tumor burden in orthotopic xenograft models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335951,1790183548,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","DOI: 10.1097/HC9.0000000000000373  \nO R IG INAL ART ICL E  \nTherapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment  \nPiyush Gondaliya1  | Julia Driscoll 1  | Irene K. Yan1  | Adil Ali Sayyed 1  | Tushar Patel 1,2   \n1Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA  \n2Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, USA  \nCorrespondence  \nTushar Patel, Department of Transplant, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224, USA.  \nEmail: [patel.tushar@mayo.edu](patel.tushar@mayo.edu)  \n\n|  | Abstract |  |\n| --- | --- | --- |\n| | Background: Impaired natural killer (NK) cell-mediated antitumor responses contribute to the growth of liver tumors. Expression of a disintegrin and metalloprotease 9 (ADAM9) increases shedding of membrane-bound major histocompatibility complex class I chain-related protein A and results in evasion from NK cell-mediated cytolysis. ADAM9 is also involved inangiogenesis and tumor progression and is a target of miR-126-3p, a tumor suppressor that is downregulated and alters tumor cell behavior in the liver and other cancers. We evaluated the restoration of miR-126-3p and modulation of the miR-126-3p/ADAM9 axis as a therapeutic approach to simultaneously enhance NK cell-mediated cytolysis while targeting both tumor cells and their microenvironment.\u003Cbr>Methods: Precursor miRNAs were loaded into milk-derived nanovesicles to generate therapeutic vesicles (therapeutic milk-derived nanovesicles) for the restoration of functional miR-126-3p in recipient cancer cells.\u003Cbr>Results: Administration of therapeutic milk-derived nanovesicles increased miR-126-3p expression and reduced ADAM9 expression in target cells and was associated with an increase in membrane-bound major histocompatibility complex class I chain-related protein A. This enhanced NK cell cytolysis in adherent tumor cells and in multicellular tumor spheroids while also impairing angiogenesis and modulating macrophage chemotaxis. Moreover, IV administration of therapeutic milk-derived nanovesicles with adoptive transfer of NK cells reduced tumor burden in orthotopic hepatocellular cancer xenografts in mice. Conclusion: A directed RNA therapeutic approach can mitigate NK cell immune evasion, reduce angiogenesis, and alter the tumor cell phenotype through the |  |\n|  |  |  |\n\nAbbreviations: ADAM9, a disintegrin and metalloprotease 9; cc, cocultured; CM, conditioned media; E:T, effector-to-target; HUVEC, human umbilical vascular endothelial cells; MTS, multicellular tumor spheroids; MICA, major histocompatibility complex I-related chain A; MNVs, milk-derived nanovesicles; NK cells, natural killer cells; NKG2D, NK receptor group 2 member D; sMICA, soluble MICA; TME, tumor microenvironment; tMNVs, therapeutic MNVs; tSNE, t-distributed stochastic neighbor embedding.  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.hepcommjournal.com.  \n-- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -  \nThis is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.  \n\n|  | restoration of miR-126-3p in liver tumor cells. The pleiotropic effects elicited by this multi-targeted approach to modulate the local tumor microenvironment support its use for the treatment of liver cancer. |  |\n| --- | --- | --- |\n|  |  |  |\n\nINTRODUCTION  \nPrimary liver cancers, such as HCC,","cbCaioO9OSBwl19u","https://ap.wps.com/l/cbCaioO9OSBwl19u","pdf",1786022,15,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Abbreviations\n# Introduction","[{\"question\":\"What problem does this study address in liver cancer?\",\"answer\":\"The study addresses NK cell dysfunction that allows tumor cells to evade NK cell–mediated cytolysis and promote tumor growth.\"},{\"question\":\"How is miR-126-3p restoration delivered?\",\"answer\":\"Precursor miRNAs are loaded into milk-derived nanovesicles to create therapeutic vesicles for restoring functional miR-126-3p in recipient cancer cells.\"},{\"question\":\"What main outcomes were observed after treatment?\",\"answer\":\"Treatment increased miR-126-3p and reduced ADAM9, enhanced MICA-mediated NK cytolysis, impaired angiogenesis, modulated macrophage chemotaxis, and reduced tumor burden in orthotopic xenograft models.\"}]","Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment | PDF",1790012918,38]